Trial Profile
A Mono centric, Double Blind, Randomized, Placebo controlled Sequential Phase-I Study to Evaluate Safety, Tolerability and Pharmacokinetics of Nasal Spray of Tapentadol HCl (Torrent Pharmaceuticals Ltd., India) following Single and Multiple Ascending Doses in Healthy Human Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- Sponsors Torrent Pharmaceuticals
- 20 Nov 2019 Status changed from recruiting to completed.
- 26 May 2016 New trial record